Mineralys Therapeutics, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Mineralys Therapeutics, Inc. has issued its proxy statement for the 2026 Annual Meeting of Stockholders, detailing proposals for director elections and auditor ratification, and providing information on executive compensation and corporate governance.
NASDAQ
Mineralys Therapeutics has filed definitive additional proxy materials with the SEC.
NASDAQ
Mineralys Therapeutics will hold its annual stockholder meeting virtually on May 22, 2025, to elect directors and ratify the appointment of its independent accounting firm.
NASDAQ
Mineralys Therapeutics has filed definitive additional proxy materials with the SEC.
NASDAQ
Mineralys Therapeutics will hold its annual stockholder meeting virtually on May 22, 2024, to elect a director and ratify the appointment of its independent accounting firm.